ATE501278T1 - Verfahren zur verwendung von il-21 - Google Patents
Verfahren zur verwendung von il-21Info
- Publication number
- ATE501278T1 ATE501278T1 AT06792239T AT06792239T ATE501278T1 AT E501278 T1 ATE501278 T1 AT E501278T1 AT 06792239 T AT06792239 T AT 06792239T AT 06792239 T AT06792239 T AT 06792239T AT E501278 T1 ATE501278 T1 AT E501278T1
- Authority
- AT
- Austria
- Prior art keywords
- individual
- predicting
- therapy
- patient
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71938805P | 2005-09-22 | 2005-09-22 | |
| PCT/EP2006/009239 WO2007039147A1 (en) | 2005-09-22 | 2006-09-22 | Methods of using il-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501278T1 true ATE501278T1 (de) | 2011-03-15 |
Family
ID=37649383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06792239T ATE501278T1 (de) | 2005-09-22 | 2006-09-22 | Verfahren zur verwendung von il-21 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070111239A1 (de) |
| EP (2) | EP2311995A1 (de) |
| JP (1) | JP5208746B2 (de) |
| AT (1) | ATE501278T1 (de) |
| AU (1) | AU2006299141B2 (de) |
| CA (1) | CA2620338A1 (de) |
| DE (1) | DE602006020601D1 (de) |
| ES (1) | ES2360728T3 (de) |
| IL (1) | IL189597A (de) |
| WO (1) | WO2007039147A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1848819A4 (de) * | 2005-02-16 | 2010-01-06 | Genetic Technologies Ltd | Verfahren zur genetischen analyse mit amplifikation komplementärer duplikate |
| AU2006299141B2 (en) * | 2005-09-22 | 2011-11-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods of using IL-21 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69322266T2 (de) | 1992-04-03 | 1999-06-02 | Perkin Elmer Corp | Proben zusammensetzung und verfahren |
| DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| US5571676A (en) | 1995-06-07 | 1996-11-05 | Ig Laboratories, Inc. | Method for mismatch-directed in vitro DNA sequencing |
| US5773346A (en) | 1995-12-06 | 1998-06-30 | Micron Technology, Inc. | Semiconductor processing method of forming a buried contact |
| US6576744B1 (en) | 1998-09-23 | 2003-06-10 | Zymogenetics, Inc. | Cytokine receptor zalpha11 |
| US6803451B2 (en) | 1998-09-23 | 2004-10-12 | Zymogenetics, Inc. | Cytokine receptor zalpha11 polypeptides |
| US6307024B1 (en) | 1999-03-09 | 2001-10-23 | Zymogenetics, Inc. | Cytokine zalpha11 Ligand |
| WO2004003156A2 (en) * | 2002-07-01 | 2004-01-08 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Il-21 as a regulator of immunoglobin production |
| EP1553970A1 (de) * | 2002-10-11 | 2005-07-20 | Novo Nordisk A/S | Behandlung von allergischen erkrankungen durch verwendung von il 21 |
| EP1782823A3 (de) * | 2002-10-11 | 2007-05-16 | Novo Nordisk A/S | IL-21 Peptiden und Nukleinsäuren |
| EP1573006B1 (de) | 2002-12-13 | 2009-11-11 | ZymoGenetics, Inc. | Il-21-produktion in prokaryontischen wirten |
| AU2006299141B2 (en) * | 2005-09-22 | 2011-11-24 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods of using IL-21 |
-
2006
- 2006-09-22 AU AU2006299141A patent/AU2006299141B2/en not_active Ceased
- 2006-09-22 US US11/534,332 patent/US20070111239A1/en not_active Abandoned
- 2006-09-22 DE DE602006020601T patent/DE602006020601D1/de active Active
- 2006-09-22 CA CA002620338A patent/CA2620338A1/en not_active Abandoned
- 2006-09-22 ES ES06792239T patent/ES2360728T3/es active Active
- 2006-09-22 JP JP2008531618A patent/JP5208746B2/ja not_active Expired - Fee Related
- 2006-09-22 AT AT06792239T patent/ATE501278T1/de active
- 2006-09-22 EP EP10185146A patent/EP2311995A1/de not_active Withdrawn
- 2006-09-22 WO PCT/EP2006/009239 patent/WO2007039147A1/en active Application Filing
- 2006-09-22 EP EP06792239A patent/EP1937838B1/de not_active Not-in-force
-
2008
- 2008-02-18 IL IL189597A patent/IL189597A/en not_active IP Right Cessation
-
2010
- 2010-06-17 US US12/817,857 patent/US20100291029A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006299141A1 (en) | 2007-04-12 |
| ES2360728T3 (es) | 2011-06-08 |
| IL189597A0 (en) | 2008-08-07 |
| IL189597A (en) | 2012-06-28 |
| EP1937838A1 (de) | 2008-07-02 |
| AU2006299141B2 (en) | 2011-11-24 |
| DE602006020601D1 (de) | 2011-04-21 |
| WO2007039147A1 (en) | 2007-04-12 |
| CA2620338A1 (en) | 2007-04-12 |
| JP5208746B2 (ja) | 2013-06-12 |
| EP2311995A1 (de) | 2011-04-20 |
| US20100291029A1 (en) | 2010-11-18 |
| EP1937838B1 (de) | 2011-03-09 |
| US20070111239A1 (en) | 2007-05-17 |
| JP2009508506A (ja) | 2009-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Expression of osteoclastogenesis inducers in a tissue model of periodontal ligament under compression | |
| CY1120384T1 (el) | Απταμερη θεραπευτικα χρησιμα στην αντιμετωπιση των σχετικων με το συμπληρωμα διαταραχων | |
| DK1567667T3 (da) | Behandling af Huntington's sygdom med EPA | |
| RS51859B (en) | METHOD FOR ANTICIPATING THE RESPONSE TO TREATMENT OF HER DIMENSION INHIBITORS | |
| ATE390925T1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| EP2239262A3 (de) | Annellierte heterocyclische Verbindungen als Kinase-Modulatoren | |
| DE602005025106D1 (de) | Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen | |
| ATE406575T1 (de) | Verfahren zur erkennung von medikamentenempfindlichkeit in patienten mit entzündungskrankheiten | |
| ATE406351T1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
| ATE375518T1 (de) | Diagnoseverfahren für erkrankungen unter verwendung von copeptin | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| MX2007006529A (es) | Seleccionar pacientes para terapia con un inhibidor her. | |
| MX342791B (es) | Ensayo elisa para la detección de vegf. | |
| DE60028830D1 (de) | Anti-april antikörper und hybridomazellen | |
| WO2008088854A3 (en) | Genetic markers for predicting responsiveness to combination therapy | |
| BRPI1006215A2 (pt) | " anticorpos multiespecíficos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, método de tratamento, método de inibição de uma atividade bíologica e uso do anticorpo " | |
| ATE359508T1 (de) | Screening-verfahren unter verwendung von zebrafisch und der blut-hirn-schranke | |
| NO20024240D0 (no) | Nye arylfruktose-1,6-bisfosfataseinhibitorer | |
| ATE413392T1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
| DE602005008325D1 (de) | Quantifizierung von Enzymaktivität mittels planarer Wellenleiter | |
| DK2005162T3 (da) | Screeningsmetode | |
| DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
| DE602005002673D1 (de) | Nukleotidsequenzvariation im Gen NS5A als Marker | |
| ATE501278T1 (de) | Verfahren zur verwendung von il-21 | |
| Sun et al. | Effect of different parameters of in vitro static tensile strain on human periodontal ligament cells simulating the tension side of orthodontic tooth movement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1937838 Country of ref document: EP |